Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry
Background. There is limited “real-world” evidence examining treatment modalities and outcomes in patients with symptomatic peripheral arterial disease undergoing endovascular treatment of femoropopliteal (FP) in-stent restenosis (ISR). Materials and Methods. We compared outcomes in 2,895 patients f...
Saved in:
Main Authors: | Michael H. Vu, Glaiza-Mae Sande-Docor, Yulun Liu, Shirling Tsai, Mitul Patel, Chris Metzger, Mehdi H. Shishehbor, Emmanouil S. Brilakis, Nicolas W. Shammas, Peter Monteleone, Subhash Banerjee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Interventional Cardiology |
Online Access: | http://dx.doi.org/10.1155/2022/5935039 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Restenosis and Therapy
by: Laszlo Denes, et al.
Published: (2012-01-01) -
In Stent Restenosis Predictors after Carotid Artery Stenting
by: Mirco Cosottini, et al.
Published: (2010-01-01) -
Novel Use of an Orbital Atherectomy Device for In-Stent Restenosis: Lessons Learned
by: K. Shaikh, et al.
Published: (2016-01-01) -
Inorganic nitrates to prevent in-stent restenosis. Is nitric oxide the Philosopher's stone?
by: Fernando Alfonso, et al.
Published: (2025-01-01) -
Swirling Flow and Wall Shear: Evaluating the BioMimics 3D Helical Centerline Stent for the Femoropopliteal Segment
by: Timothy M. Sullivan, et al.
Published: (2018-01-01)